MARKET

GNFTF

GNFTF

Genfit S A
OTCPK
10.88
NaN%
Closed 09:30 04/06 EDT
OPEN
--
PREV CLOSE
10.88
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
10.88
52 WEEK LOW
4.140
MARKET CAP
544.03M
P/E (TTM)
-11.9495
1D
5D
1M
3M
1Y
5Y
1D
Genfit Receives FDA Orphan Drug Designation For NTZ In Acute-on-Chronic Liver Failure
NASDAQ · 03/10 03:32
Analysts Have Conflicting Sentiments on These Healthcare Companies: MoonLake Immunotherapeutics (MLTX) and Genfit (OtherGNFTF)
TipRanks · 03/01 19:10
Time To Take Profits On Gilead Sciences (Rating Downgrade)
Seeking Alpha · 02/20 19:24
Analysts’ Top Healthcare Picks: Genfit (GNFTF), Nyxoah (NYXH)
TipRanks · 02/15 01:40
Genfit adds $20M as Ipsen records strong sales for liver drug
Seeking Alpha · 02/12 18:52
Gilead Sciences: From All-Time Highs To Higher Highs
Seeking Alpha · 01/12 22:40
Kepler Capital Remains a Buy on Genfit (GNFTF)
TipRanks · 01/09 01:37
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Genfit (OtherGNFTF) and Agios Pharma (AGIO)
TipRanks · 11/21/2025 01:40
More
About GNFTF
Genfit SA is a France-based biopharmaceutical company focused on the discovery and development of therapeutic and diagnostic solutions in the field of liver diseases, particularly of metabolic origin, where unmet medical needs are considerable, particularly due to a lack of approved treatments. The Company provides therapeutic and diagnostic solutions for rare and serious liver diseases , with a particular interest in diseases with largely unmet medical needs. Its laboratory capabilities include pharmacology, molecular and cellular biology, drug candidate screening, medicinal and analytical chemistry, biochemistry, omics analyses, and data science. Its in-house biobank allows to have unparalleled control and precision in the handling and preservation of biological samples, which is crucial to research. The Company leverage artificial intelligence (image processing tools and language models) to create tools that accelerate daily work and decision-making.

Webull offers Genfit SA stock information, including OTCPK: GNFTF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GNFTF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading GNFTF stock methods without spending real money on the virtual paper trading platform.